Call Options Transactions Made in Q3 2023 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q3 2023. The information is specifically focused on institutions that hold call options of Celldex Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
200KNew |
$5.09M - $7.49M
|
200K
$5.16M
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
103K+ 120.14% |
$2.61M - $3.84M
|
188K
$4.85M
|
|
|
Nov 14, 2023
Q3 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
CALL |
100KNew |
$2.55M - $3.75M
|
100K
$2.58M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
54.4K+ 287.83% |
$1.38M - $2.04M
|
73.3K
$1.89M
|
|
|
Nov 14, 2023
Q3 2023
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
3K+ 1500.0% |
$76.4K - $112K
|
3.2K
$82.5K
|
|
|
Nov 14, 2023
Q3 2023
|
Walleye Trading LLC
Plymouth, MN |
SELL
|
CALL |
-700- 46.67% |
$17.8K - $26.2K
|
800
$20.6K
|